Your browser doesn't support javascript.
loading
Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice.
Luo, Jiang-Yun; Cheng, Chak Kwong; Gou, Lingshan; He, Lei; Zhao, Lei; Zhang, Yang; Wang, Li; Lau, Chi Wai; Xu, Aimin; Chen, Alex F; Huang, Yu.
Afiliação
  • Luo JY; Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cheng CK; School of Biomedical Sciences and Shenzhen Research Institute, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Gou L; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, China.
  • He L; Center for Genetic Medicine, Xuzhou Maternity and Health Care Hospital, Jiangsu, China.
  • Zhao L; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Zhang Y; School of Biomedical Sciences and Shenzhen Research Institute, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wang L; School of Public Health (Shenzhen), Sun Yat-sen University, Guangdong, China.
  • Lau CW; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Xu A; School of Biomedical Sciences and Shenzhen Research Institute, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chen AF; State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Huang Y; Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Diabetes ; 72(9): 1330-1342, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37347764
Diabetic endothelial dysfunction associated with diminished endothelial nitric oxide (NO) synthase (eNOS) activity accelerates the development of atherosclerosis and cardiomyopathy. However, the approaches to restore eNOS activity and endothelial function in diabetes remain limited. The current study shows that enhanced expression of Krüppel-like factor 2 (KLF2), a shear stress-inducible transcription factor, effectively improves endothelial function through increasing NO bioavailability. KLF2 expression is suppressed in diabetic mouse aortic endothelium. Running exercise and simvastatin treatment induce endothelial KLF2 expression in db/db mice. Adenovirus-mediated endothelium-specific KLF2 overexpression enhances both endothelium-dependent relaxation and flow-mediated dilatation, while it attenuates oxidative stress in diabetic mouse arteries. KLF2 overexpression increases the phosphorylation of eNOS at serine 1177 and eNOS dimerization. RNA-sequencing analysis reveals that KLF2 transcriptionally upregulates genes that are enriched in the cyclic guanosine monophosphate-protein kinase G-signaling pathway, cAMP-signaling pathway, and insulin-signaling pathway, all of which are the upstream regulators of eNOS activity. Activation of the phosphoinositide 3-kinase-Akt pathway and Hsp90 contributes to KLF2-induced increase of eNOS activity. The present results suggest that approaches inducing KLF2 activation, such as physical exercise, are effective to restore eNOS activity against diabetic endothelial dysfunction. ARTICLE HIGHLIGHTS: Exercise and statins restore the endothelial expression of Krüppel-like factor 2 (KLF2), which is diminished in diabetic db/db mice. Endothelium-specific overexpression of KLF2 improves endothelium-dependent relaxation and flow-mediated dilation through increasing nitric oxide bioavailability. KLF2 promotes endothelial nitric oxide synthase (eNOS) coupling and phosphorylation in addition to its known role in eNOS transcription. KLF2 upregulates the expression of several panels of genes that regulate eNOS activity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasodilatação / Diabetes Mellitus Experimental / Óxido Nítrico Sintase Tipo III Limite: Animals Idioma: En Revista: Diabetes Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasodilatação / Diabetes Mellitus Experimental / Óxido Nítrico Sintase Tipo III Limite: Animals Idioma: En Revista: Diabetes Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China